Cleared Traditional

K162412 - Hoggan Scientific microFET2

K162412 is an FDA 510(k) clearance for Hoggan Scientific microFET2, manufactured by Hoggan Scientific, LLC. The device is a Class 2 Neurology device with product code LBB cleared through the Traditional 510(k) pathway after a 192-day FDA review.

K162412 · Hoggan Scientific, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
192d
Days
Class 2
Risk

K162412 is an FDA 510(k) clearance for the Hoggan Scientific® microFET2™. Classified as Dynamometer, Ac-powered (product code LBB), Class II - Special Controls.

Submitted by Hoggan Scientific, LLC (Salt Lake City, US). The FDA issued a Cleared decision on March 9, 2017 after a review of 192 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 888.1240 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hoggan Scientific, LLC devices

FDA 510(k) Submission Details - K162412

510(k) Number K162412 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2016
Decision Date March 09, 2017
Days to Decision 192 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
44d slower than avg
Panel avg: 148d · This submission: 192d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LBB Device Classification - Class 2, Special Controls

Product Code LBB Dynamometer, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.1240
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.